Comprehensive biomarker profiling of matched primary and metastatic estrogen receptor positive breast cancers

被引:0
|
作者
Spoerke, Jill M. [1 ]
Schleifman, Erica B. [1 ]
Desai, Rupal [1 ]
Xiao, Yuanyuan [1 ]
Wong, Cheryl [1 ]
Abbas, Ilma [1 ]
O'Brien, Carol [1 ]
Patel, Rajesh [1 ]
Sumiyoshi, Teiko [1 ]
Fu, Ling [1 ]
Tam, Rachel [1 ]
Koeppen, Hartmut [1 ]
Wilson, Timothy [1 ]
Raja, Rajiv [1 ]
Hampton, Garret M. [1 ]
Lackner, Mark R. [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
关键词
D O I
10.1158/1557-3125.ADVBC-B024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B024
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer
    Fowler, Amy M.
    Salem, Kelley
    DeGrave, Michael
    Ong, Irene M.
    Rassman, Shane
    Powers, Ginny L.
    Kumar, Manoj
    Michel, Ciara J.
    Mahajan, Aparna M.
    HORMONES & CANCER, 2020, 11 (02): : 63 - 75
  • [22] The correlation of ESR1 genetic aberrations with estrogen receptor and progesterone receptor status in metastatic and primary estrogen receptor-positive breast carcinomas*
    Moreira-Dinzey, Jennifer
    Zhan, Haiying
    Rozenblit, Mariya
    Krishnamurti, Uma
    Harigopal, Malini
    Zhong, Minghao
    Liang, Yuanxin
    HUMAN PATHOLOGY, 2023, 137 : 56 - 62
  • [23] Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
    Castellano, Isabella
    Allia, Elena
    Accortanzo, Valeria
    Vandone, Anna Maria
    Chiusa, Luigi
    Arisio, Riccardo
    Durando, Antonio
    Donadio, Michela
    Bussolati, Gianni
    Coates, Alan S.
    Viale, Giuseppe
    Sapino, Anna
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (03) : 607 - 617
  • [24] Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
    Isabella Castellano
    Elena Allia
    Valeria Accortanzo
    Anna Maria Vandone
    Luigi Chiusa
    Riccardo Arisio
    Antonio Durando
    Michela Donadio
    Gianni Bussolati
    Alan S. Coates
    Giuseppe Viale
    Anna Sapino
    Breast Cancer Research and Treatment, 2010, 124 : 607 - 617
  • [25] Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer
    Goldberg, Jonathan
    Qiao, Na
    Guerriero, Jennifer L.
    Gross, Brett
    Meneksedag, Yagiz
    Lu, Yoshimi F.
    Philips, Anne V.
    Rahman, Tasnim
    Meric-Bernstam, Funda
    Roszik, Jason
    Chen, Ken
    Jeselsohn, Rinath
    Tolaney, Sara M.
    Peoples, George E.
    Alatrash, Gheath
    Mittendorf, Elizabeth A.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 496 - 504
  • [26] Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers
    Cotul, Eylem Kulkoyluoglu
    Zuo, Qianying
    Santaliz-Casiano, Ashlie
    Imir, Ozan Berk
    Mogol, Ayca Nazli
    Tunc, Elif
    Duong, Kevin
    Lee, Jenna Kathryn
    Ramesh, Rithva
    Odukoya, Elijah
    Kesavadas, Mrinali P.
    Ziogaite, Monika
    Smith, Brandi Patrice
    Mao, Chengjian
    Shapiro, David J.
    Park, Ben Ho
    Katzenellenbogen, Benita S.
    Daly, Drew
    Aranda, Evelyn
    O'Neill, John D.
    Walker, Christopher
    Landesman, Yosef
    Madak-Erdogan, Zeynep
    CANCERS, 2020, 12 (09) : 1 - 22
  • [27] Novel strategies for treating estrogen receptor positive metastatic breast cancer
    Xiong, Rui
    Zhao, Jiong
    Gutgesell, Lauren
    Li, Yangfeng
    Lu, Yunlong
    Rosales, Carlo
    Zhao, Huiping
    Tonetti, Debra
    Thatcher, Gregory
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [28] GATA3 Is a Marker of Estrogen Receptor-Positive but Not Estrogen Receptor-Negative Breast Cancers
    Piscuoglio, S.
    Wen, Y. H.
    Martelotto, L. G.
    Rocco, E. Guerini
    Akram, M.
    Jungbluth, A. A.
    Brogi, E.
    Weigelt, B.
    Reis-Filho, J. S.
    MODERN PATHOLOGY, 2014, 27 : 76A - 76A
  • [29] GATA3 Is a Marker of Estrogen Receptor-Positive but Not Estrogen Receptor-Negative Breast Cancers
    Piscuoglio, S.
    Wen, Y. H.
    Martelotto, L. G.
    Rocco, E. Guerini
    Akram, M.
    Jungbluth, A. A.
    Brogi, E.
    Weigelt, B.
    Reis-Filho, J. S.
    LABORATORY INVESTIGATION, 2014, 94 : 76A - 76A
  • [30] Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
    Raj, Ganesh V.
    Sareddy, Gangadhara Reddy
    Ma, Shihong
    Lee, Tae-Kyung
    Viswanadhapalli, Suryavathi
    Li, Rui
    Liu, Xihui
    Murakami, Shino
    Chen, Chien-Cheng
    Lee, Wan-Ru
    Mann, Monica
    Krishnan, Samaya Rajeshwari
    Manandhar, Bikash
    Gonugunta, Vijay K.
    Strand, Douglas
    Tekmal, Rajeshwar Rao
    Ahn, Jung-Mo
    Vadlamudi, Ratna K.
    ELIFE, 2017, 6